Davenport is named new Sermo CEO

Share this article:
Tim Davenport
Tim Davenport

Sermo has named former Revolution Health president Tim Davenport CEO. Daven­port replaces the physician online community's founder, Dr. Daniel Palestrant, who left the firm, with chief medical officer Dr. Adam Sharp, in November to launch a startup called Par80.

“I am delighted to lead Sermo, an innovative company I have watched closely since it became the early leader in creating online community for physicians,” said Davenport.

VP marketing and member­ship Jon Michaeli said the seven-year-old firm is reaching out to its physician membership to fill medical advisory board seats, of which there will be up to five.

Backed by such venture capital firms as Longworth Venture Partners, SoftBank Capital and Legg Mason Capital, Sermo has struggled to convert buzz and big-name partnerships into profitability. The company made deep cuts in late 2009. Some said missteps, including an AMA partnership that went sour and the site's policy of letting docs remain anonymous in interactions with each other, contributed to slow commercial growth.

Meanwhile, would-be competitors, like Doximity and PeerCase, have sprung up and begun to generate buzz on the Silicon Valley venture-capital circuit. Doximity has attracted more than 40,000 members. As of mid-February, Sermo boasted a physician membership of around 125,000.

Michaeli said the firm was working on new offerings including “partnerships outside of the normal business model.” Sermo has previously counted Pfizer and J&J's Janssen as partners.

As for Drs. Palestrant and Sharp, their venture is based on the belief that spiraling healthcare spending will cause the collapse of the nation's healthcare system. Since a European-style single-payer system is politically infeasible, Sharp and Palestrant theorize that we'll wind up with a more market-based and consumer-driven system. They'll reveal more about their solution later in the year, they say.

Still warring with the AMA, Palestrant and Sharp blame the society's CPT codes for a lack of pricing transparency. “It fuels the AMA's conflict of interest and makes it impossible for any of us to understand the actual cost of healthcare,” said Palestrant.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.